Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.